Navigation Links
Raising Awareness of Rare Diseases, Anson Group Announces Sponsorship of Rare Disease Day
Date:2/27/2010

Anson Group, a sponsor for Rare Disease Day, hopes to bring more attention to the need for finding more treatments for diseases which affect a smaller patient population.

Indianapolis, IN (Vocus) February 27, 2010 -- The Anson Group hopes to draw more attention to the urgent need of finding more treatments for rare diseases by partnering with the National Organization for Rare Diseases (NORD) to sponsor Rare Disease Day in the United States, February 28th, 2010.

Anson Group, a regulatory consulting company, has had the privilege of providing regulatory support for multiple products that are indicated for the treatment of a number of rare diseases. Anson has aided clients in obtaining Orphan Drug status (for pharmaceutical entities) and Humanitarian Use Designations (for medical devices) for products intended to treat diseases like gastrointestinal stromal tumor (GIST), mastocytosis and multiple myeloma, as well as multiple sclerosis and amyotrophic lateral sclerosis (ALS). Most recently, Anson Group helped prepare materials for an FDA Advisory Committee meeting regarding a new treatment for Niemann-Pick Type C (NPC) disease.

Anson supports the need for continued research and innovation in rare diseases. As scientists continue to work to evolve treatments to target more specific disease pathways, subpopulations and rare diseases will become increasingly important in the understanding and practice of true personalized medicine. Anson Group will continue to invest in building our expertise in regulatory requirements for these products in order to expand our role in ensuring promising treatments reach the market for those who suffer from rare conditions.

“Anson is proud of our 15 year history of helping all of our clients get their medical technologies to market as quickly as possible and in compliance with the applicable regulations; that said, no project
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
2. Volatile Economy / Fundraising Challenges Encourage Business Combinations Among Biotech Companies According to New Survey from CPA Firm Rothstein Kass
3. Novagali Pharma Completes a EUR15 Million Fund Raising
4. Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital Fund
5. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
6. Spectrum Announces Support Partnership for Breast Cancer Research During Breast Cancer Awareness Month
7. Accera, Inc. to Support the Alzheimers Foundation of Americas National Memory Screening Day Through On-line Awareness Effort
8. TSH Testing Raises Awareness of Importance of Thyroid Health
9. First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009
10. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
11. Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Raising Awareness of Rare Diseases, Anson Group Announces Sponsorship of Rare Disease Day
(Date:1/15/2014)... 15, 2014   Niagara Thermal Products is proud ... BioBlower Technologies LLC ("B3") as the critical thermal component ... from the Army Corps of Engineers.  B3 has developed ... biological contaminants and destroys VOCs and other chemical pollutants, ...
(Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
(Date:1/15/2014)... 15, 2014 DTS Language Services, Inc ... Web Portal for Life Science organizations who need document translations. ... subject matter of their documents in advance with a selection ... time-to-delivery of translations, often a critical factor in clinical and ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 p.m. – ... Warrington, Pa. , Details: The Hepatitis B Foundation, ... cure for hepatitis B and improving the quality of life ... on Friday, April 11 at Warrington Country Club in Warrington, ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Nets to Prevent Serious Health Hazards ... Associated with Diethylene ... Pharmacopeial (USP),Convention today announced a revised Glycerin monograph in ... United States. The,revision strengthens safety nets to prevent serious ...
... The following was issued,today by the Greater Baltimore ... CEO, Greater Baltimore Committee, 140 company owners, executives ... The third annual Greater Baltimore Region Bioscience Awards, ... / Breakfast & Registration, 8:45 - 9:30 a.m. ...
... March 17 Mercury Therapeutics,Inc. (MTI), a ... protein,kinase targeted drugs, announces that it has ... advise on its strategic and partnering,opportunities, with ... shareholders., This appointment follows a significant ...
Cached Biology Technology:USP Announces Revised Glycerin Monograph 2USP Announces Revised Glycerin Monograph 3Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 3
(Date:7/9/2014)... of a sparrow-sized fossil from China challenges the commonly ... that gained the ability to fly. The birdlike fossil ... much rather the remains of a tiny tree-climbing animal ... the Dinosaur Museum in Blanding, Utah, and Alan Feduccia ... in Springer,s Journal of Ornithology . , The ...
(Date:7/9/2014)... results accrue. To completely and systematically archive this ... fact, researchers in the life sciences spend a ... an online survey of 70 people working in ... Applied Information Technology FIT in Sankt Augustin. Many ... centralized or structured approach to data collection in ...
(Date:7/9/2014)... in their blood are more likely to survive the disease, ... of vitamin D have half the risk of dying compared ... The study is the first to correlate total blood levels ... which includes that produced after exposure to sunlight and ... survival prospects. , The University of Edinburgh team tested ...
Breaking Biology News(10 mins):Researchers declassify dinosaurs as being the great-great-grandparents of birds 2Managing the data jungle 2Managing the data jungle 3
... addictive substance in cigarette smoke, contributes to smokers, higher ... attacks, according to research to be presented Sunday, Dec. ... Meeting in New Orleans. These findings suggest ... steam without the carcinogenic agents of tobacco smoke, may ...
... An experimental drug that targets macrophages, a type of ... tumor glioblastoma multiforme decreased the cancer,s growth and extended ... report on Tuesday Dec. 17, at the American Society ... The rates of apoptosis, or programmed cell death, ...
... A cross-sectional study by investigators from Tokyo University has ... factor against sarcopenia and effective in maintaining muscle strength ... the ageing process, resulting in loss of skeletal muscle ... The multiple adverse health outcomes include physical disability, poor ...
Cached Biology News:Nicotine drives cell invasion that contributes to plaque formation in coronary arteries 2Blocking tumor-associated macrophages decreased glioblastoma's growth & extended survival in mice 2
... UltraPure Agarose and SYBR Safe DNA Gel Stain ... Saves money versus buying these same products separately ... alternative to ethidium bromide ... Agarose resolves DNA and RNA fragments from 100 bp ...
Anti-WT-1 Liquid. In 10 μM PBS, 0.2 % BSA, pH 7.6. Recognizes the ~47-55 kDa Wilm's tumor protein in Wilm's tumor tissue. ...
... uses continuous chemical suppression and thermally stabilized ... accurate determinations of common anions and cations ... quick to equilibrate, and fully automated with ... you achieve maximum sample throughput at minimum ...
... siRNA applications, contains magnetic nanoparticles (MagTag) which ... of interest. Exploiting magnetic force the full ... towards and delivered into the target cells ... be used for adherent cells; for suspension ...
Biology Products: